Literature DB >> 20949211

Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study.

Fernanda Sousa1, Subhra Mandal, Chiara Garrovo, Alberto Astolfo, Alois Bonifacio, Diane Latawiec, Ralf Hendrik Menk, Fulvia Arfelli, Sabine Huewel, Giuseppe Legname, Hans-Joachim Galla, Silke Krol.   

Abstract

In the present study, the in vivo distribution of polyelectrolyte multilayer coated gold nanoparticles is shown, starting from the living animal down to cellular level. The coating was designed with functional moieties to serve as a potential nano drug for prion disease. With near infrared time-domain imaging we followed the biodistribution in mice up to 7 days after intravenous injection of the nanoparticles. The peak concentration in the head of mice was detected between 19 and 24 h. The precise particle distribution in the brain was studied ex vivo by X-ray microtomography, confocal laser and fluorescence microscopy. We found that the particles mainly accumulate in the hippocampus, thalamus, hypothalamus, and the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949211     DOI: 10.1039/c0nr00345j

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  26 in total

Review 1.  Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.

Authors:  Sibel Bozdağ Pehlivan
Journal:  Pharm Res       Date:  2013-10       Impact factor: 4.200

Review 2.  Current Status and Future Direction of Nanomedicine: Focus on Advanced Biological and Medical Applications.

Authors:  Eun-Mi Kim; Hwan-Jeong Jeong
Journal:  Nucl Med Mol Imaging       Date:  2016-08-09

3.  Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1-42 Mouse Model of Alzheimer's Disease.

Authors:  Tahir Ali; Min Ju Kim; Shafiq Ur Rehman; Ashfaq Ahmad; Myeong Ok Kim
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

Review 4.  Imaging of cells and nanoparticles: implications for drug delivery to the brain.

Authors:  Katica Stojanov; Inge S Zuhorn; Rudi A J O Dierckx; Erik F J de Vries
Journal:  Pharm Res       Date:  2012-07-18       Impact factor: 4.200

5.  Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain.

Authors:  Rishabh Agarwal; Miriam S Domowicz; Nancy B Schwartz; Judy Henry; Igor Medintz; James B Delehanty; Michael H Stewart; Kimihiro Susumu; Alan L Huston; Jeffrey R Deschamps; Philip E Dawson; Valle Palomo; Glyn Dawson
Journal:  ACS Chem Neurosci       Date:  2015-03-05       Impact factor: 4.418

6.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

Review 7.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

8.  Discovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats.

Authors:  Wolfgang G Kreyling
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-06       Impact factor: 4.219

Review 9.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

10.  The effect of titanium dioxide nanoparticles on neuroinflammation response in rat brain.

Authors:  Intissar Grissa; Sabrine Guezguez; Lobna Ezzi; Sana Chakroun; Amira Sallem; Emna Kerkeni; Jaber Elghoul; Lassaad El Mir; Meriem Mehdi; Hassen Ben Cheikh; Zohra Haouas
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-21       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.